Kiran Sampley

Kiran Sampley practices at Dignity Health - Mercy General Hospital in Sacramento, California, part of CommonSpirit Health.

Kiran Sampley's NPI, 1598145708, was assigned on June 3, 2015. Kiran Sampley holds California license A156624.

Kiran Sampley's primary practice is Dignity Health - Mercy General Hospital, at 4001 J St, Sacramento, CA 95819 in Sacramento County. The practice phone is (916) 453-4453.

Kiran Sampley's primary practice is Dignity Health - Mercy General Hospital in Sacramento, California, part of CommonSpirit Health. Kiran Sampley is also affiliated with Dignity Health - Methodist Hospital of Sacramento. The medical group on file is Mercy Medical Group. Dmand AI also links Kiran Sampley to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kiran Sampley practices, 6 sites in all. Vendor and product names are available with a free account.

Hospitalist is Kiran Sampley's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Kiran Sampley's licenses on file in 2 states: California and Michigan.

CMS data shows 585 Medicare services from Kiran Sampley across 4 procedure codes in 2024, for 248 Medicare patients. Medicare paid $56,604 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 248 Medicare patients who saw Kiran Sampley in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 58% are also on Medicaid. Their average risk score is 2.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kiran Sampley's median patient age at 66, with 51% women.

In 2024, Kiran Sampley wrote 379 Medicare Part D claims for 144 patients. 84% of them were for generic drugs. CMS names the drug for 141 of them, across 8 drugs with 11 or more claims each, at $9,965 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Kiran Sampley for performance year 2024, reported through an alternative payment model (APM). Kiran Sampley accepts Medicare assignment, so Medicare's approved amount is taken as full payment.